Proliferative glioblastoma cancer cells exhibit persisting temporal control of metabolism and display differential temporal drug susceptibility in chemotherapy by Wagner, Paula Micaela et al.
Proliferative Glioblastoma Cancer Cells Exhibit Persisting Temporal
Control of Metabolism and Display Differential Temporal Drug
Susceptibility in Chemotherapy
Paula M. Wagner1,2 & Lucas G. Sosa Alderete1,2,3 & Lucas D. Gorné4,5 & Virginia Gaveglio6 & Gabriela Salvador6 &
Susana Pasquaré6 & Mario E. Guido1,2
Received: 1 December 2017 /Accepted: 24 May 2018
# Springer Science+Business Media, LLC, part of Springer Nature 2018
Abstract
Even in immortalized cell lines, circadian clocks regulate physiological processes in a time-dependent manner, driving transcrip-
tional and metabolic rhythms, the latter being able to persist without transcription. Circadian rhythm disruptions in modern life
(shiftwork, jetlag, etc.) may lead to higher cancer risk. Here, we investigated whether the human glioblastoma T98G cells
maintained quiescent or under proliferation keep a functional clock and whether cells display differential time responses to
bortezomib chemotherapy. In arrested cultures, mRNAs for clock (Per1, Rev-erbα) and glycerophospholipid (GPL)-synthesizing
enzyme genes, 32P-GPL labeling, and enzyme activities exhibited circadian rhythmicity; oscillations were also found in the redox
state/peroxiredoxin oxidation. In proliferating cells, rhythms of gene expression were lost or their periodicity shortened whereas
the redox and GPL metabolisms continued to fluctuate with a similar periodicity as under arrest. Cell viability significantly
changed over time after bortezomib treatment; however, this rhythmicity and the redox cycles were altered after Bmal1 knock-
down, indicating cross-talk between the transcriptional and the metabolic oscillators. An intrinsic metabolic clock continues to
function in proliferating cells, controlling diverse metabolisms and highlighting differential states of tumor suitability for more
efficient, time-dependent chemotherapy when the redox state is high and GPL metabolism low.
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Introduction
In mammals, the circadian timing system generates periodic
oscillations in many physiological processes and behaviors,
allowing the organism to anticipate and adapt to daily envi-
ronmental changes and thus be in synchrony with the solar
cycle. Circadian clocks are present in most tissues examined
and even in immortalized cell lines and primary cell cultures
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displaying self-sustained rhythms in gene expression and met-
abolic activities [1–4]. At the molecular level, the clock is
controlled by a transcriptional/translational feedback circuitry
involving a set of so-called clock genes such as Clock, Bmal1,
Periods (Per), and Cryptochromes (Cry), among others,
encoding for the corresponding clock proteins acting as regu-
latory transcription factors (activators or repressors) able to
generate rhythms of clock gene and clock-controlled gene
expression under a circadian base [5]. Through their rhythmic
transcription, circadian clock genes regulate the metabolism
and respiration of cells, therefore becoming very important
regulators of the cell division cycle [6]. Loss of clock gene
function or misalignment of circadian rhythms may therefore
lead to diverse metabolic disorders (obesity, diabetes, hyper-
lipidemia, etc.) [7] and higher risk of cancer by inducing ma-
lignant cell growth and tumor development [6].
Carcinogenesis is a process resulting in the accumulation
of genetic alterations primarily in genes involved in the regu-
lation of signaling pathways relevant to the regulation of cell
growth and division (reviewed in [8]). Characteristics typical
of neoplastic processes include sustained proliferative activa-
tion, growth suppressor evasion, cell death resistance, replica-
tive immortality, induction of angiogenesis, and invasiveness
and metastasis, all of which are based on genome instability
and inflammation. In this context, knowledge at the molecular
level of circadian biology can contribute significantly to the
understanding and potential treatment of human pathologies,
in particular cancer and metabolic and behavioral disorders [6,
9]. Moreover, recent transcriptomic, proteomic, and
metabolomic studies in mammalian tissues have shown a ro-
bust crosslink between the circadian clock and cellular metab-
olism in general and glycerophospholipid (GPL) homeostasis
and metabolism in particular [10–13].
In addition, a redox/metabolic clock that drives
peroxiredoxin (PRX) oxidation cycles has recently been re-
ported to operate even in the absence of transcription and
shown to be highly conserved through evolution and present
in all different kingdoms of life [14, 15]. On the basis of this
new evidence, it can be inferred that there is an intrinsic clock
at the cellular level, comprising the transcriptional clock and
metabolic oscillators that temporally control a plethora of cel-
lular processes. GPLs constitute a fundamental group of lipids
with important roles as structural components of all biological
membranes and key cellular components involved in cell sig-
naling, energy balance, vesicular transport, cell division, apo-
ptosis , and cel l - to-cel l communicat ion [16, 17].
Phosphatidylcholine (PC) and phosphatidylethanolamine
(PE) are the most abundant GPLs present in all eukaryotic
cells; they are first synthesized from glycerol-3-phosphate
via a de novo pathway described by Kennedy and Weiss
[17, 18] and subsequently remodeled by the Lands Cycle,
involving the sequential activity of phospholipases A (PLA)
and lysophospholipid acyltransferases (LPLAT) [19, 20]. For
PC biosynthesis, the Kennedy pathway involves three enzy-
matic steps catalyzed by choline kinase (ChoK), CTP/
phosphocholine cytidylyltranferase (CCT), and CDP-cho-
line/1,2-diacylglycerol choline phosphotransferase (CPT) in
which CCT activity is considered the rate-limiting and regu-
latory step under most metabolic conditions [21].
Nevertheless, it has been demonstrated that the availability
of diacylglycerol (DAG) and regulation of ChoK also influ-
ence PC biosynthesis [22–24]. In most mammals, there are
two genes encoding for ChoK: Chka codes for ChoKα1/2
and Chkb codes for ChoKβ [25, 26]. Mice lacking ChoKα
die early in embryogenesis [25, 26], whereas ChoK overex-
pression has been implicated in human carcinogenic processes
[25, 26]. In addition, ChoKα expression and/or activity are
subject to circadian control in both cultured fibroblasts and
mice liver after synchronization [3, 4, 27]. In mammalian
cells, PE is mainly de novo synthesized from the CDP-
ethanolamine Kennedy pathway in which ethanolamine
(Etn) is phosphorylated to Etn-P by the Etn kinase (EK) and
then converted to CDP-Etn by CTP/phosphoethanolamine
cytidylyltranferase (Pcyt2). In the last step, CDP-Etn is trans-
ferred to DAG to produce PE by the CDP-Etn/1,2-
diacylglycerol ethanolamine phosphotransferase (EPT).
Pcyt2 is the main regulatory enzyme in the de novo biosyn-
thesis of PE (for a review, see [28]). In mammals, the disrup-
tion of genes encoding GPL biosynthetic enzymes has severe
physiological consequences during development and can be
lethal [25, 26].We have previously reported that de novo syn-
thesis of whole GPLs in different cell types from mammalian
and non-mammalian vertebrates is controlled by a circadian
clock, as observed in chicken retinal neurons in vivo or in
vitro [29–31], in the liver of mice synchronized to light-dark
cycles [4], as well as in quiescent murine fibroblasts after
synchronization by a serum shock [3, 32]. Furthermore, the
biosynthesis of membrane GPLs including PC and PE is of
crucial significance for cell growth and progression through
the cell cycle, whereas deregulated proliferation is a hallmark
of cancer cells [8]. Although circadian clocks influence the
cell division cycle through complex regulatory circuits, dereg-
ulation of core clock gene expression and loss of circadian
homeostasis may promote cancer development [6, 33]. At
present, little is known about the temporal regulation of GPL
biosynthesis in immortalized tumor cells. We therefore inves-
tigated whether human glioblastoma T98G cells subject to
proliferation in the presence of serum or maintained quiescent
(arrested) in a serum-free medium retain a functional clock
capable of regulating gene expression at the molecular level
and redox and GPLmetabolism under a circadian base. To this
end, we first examined the expression of clock core genes
(Per1 and Rev-erbα) and GPL-synthesizing enzyme genes
(ChoKα and Pcyt-2) for PC and PE biosynthetic pathways,
respectively, in proliferating and quiescent cells at different
times after dexamethasone (DEX, 100 nM) synchronization.
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We also assessed whether redox metabolism (redox state and
peroxiredoxin oxidation cycles), the metabolic labeling of
32P-GPLs, and the activities of GPL-synthesizing enzyme
phosphatidate phosphohydrolase (PAP) and LPLATs were
temporally regulated in synchronized T98G cells after DEX
synchronization under both proliferative conditions. We fur-
ther assessed the susceptibility of proliferating cells over time
to treatment with the proteasome inhibitor bortezomib, a
known chemotherapeutic agent. Lastly, we investigated the
role of the transcriptional clock in redox cycle rhythms and
chemotherapeutic susceptibility in proliferating cells in which
Bmal1 expression was knocked-down by CRISPR/cas9
technology.
Results
Characterization of T98G Cell Culture Conditions
T98G glioblastoma cells display typical cancer cell character-
istics and are thus subject to continuous proliferation, as a
result of which no inhibition by contact is observed when cells
are maintained in culture. One round of division along the cell
cycle takes close to 24–28 h.
To investigate the temporal regulation of GPL synthesis,
redox metabolism and expression of clock and clock-
controlled genes in T98G cells, we first characterized the ex-
perimental culture conditions in relation to proliferation
levels. To this end, cells grown to 50% of confluence in
10% fetal bovine serum (FBS)-Dulbecco’s modified Eagle’s
medium (DMEM) were synchronized with a 20-min 100 nM
DEX shock and then maintained in the presence of a 5%
serum medium (proliferative) or in an FBS-free medium
(arrested) to achieve quiescence for 24 h. Irrespective of the
cell cycle itself, a synchronization protocol is essential to ad-
just individual cells within the whole culture population to the
same phase. We examined whether cells undergo a significant
rate of cell division after DEX synchronization under both
FBS conditions. We found by flow cytometry that within the
first 24 h, most cells in this serum-free state were arrested at
the G0/G1 phases (~ 71–80%) while < 12–17% of cells
reached the G2/M and S phases (Supplementary Fig. 1a).
The distribution of cell populations throughout the cell cycle
remained constant at all times examined. These two major
features—the basal proliferative condition and synchroniza-
tion by an external factor—make T98G cell cultures an inter-
esting oscillator model for circadian studies, in a cancer con-
text, regardless of cell division and systemic influences from
the brain’s master clock. At times after at least 8 h of DEX
treatment, ~ 60% of cells maintained in the presence of FBS
after synchronization were arrested at the G0/G1 phases and ~
30% at the G2/M and S phases (Supplementary Fig. 1a). The
distribution of cell populations throughout the cell cycle in the
presence of FBS medium remained constant at most times
examined up to 48 h, with an average of ~ 35% of cells in
the G2/M and S phases. On the contrary, at time 0 with no
DEX treatment and during the first hour after treatment, cells
exhibited the highest percentage at phase S + G2/M (50–65%)
and the lowest for Go/G1 (30–40%) as compared with DEX-
treated cells at longer times (Supplementary Fig. 1a, b). Based
on these observations, it can be inferred that once synchro-
nized, cells from the two conditions (proliferative and
arrested) represent different proliferative situations, making
them suitable for circadian studies. In addition, when the mo-
lecular clock was perturbed in proliferating T98G cells after
transfection with PX459-Bmal1 plasmid in order to knock-
down Bmal1 expression (Supplementary Fig. 1a, c, d), there
was a higher percentage of arrested cells (77%) in the G0/G1
phases than in the controls (61%).
Temporal Regulation of Clock Gene Expression
in T98G Cells Under Different Proliferation Conditions
T98G cells synchronized with a brief DEX shock and
maintained arrested in an FBS-free medium displayed a
significant temporal variation in mRNA levels for the
clock genes Per1 and Rev-erbα along the 48 h examined,
wi th marked ly d i ffe ren t prof i l es o f express ion
(Supplementary Fig. 1b) and a periodicity according to a
COSINOR/RAIN analysis ranging from 24 to 28 h
(Table 1). It is noteworthy that Bmal1 was highly
expressed at time 0 and 24 h after synchronization and
lowest levels were seen at 16 h (data not shown), whereas
Per1 and Rev-erbα transcripts exhibited patterns of expres-
sion in total antiphase with Bmal1 mRNA (Supplementary
Fig. 1b). In fact, highest levels of mRNA for Per1 and Rev-
erbα were observed around 16 h after synchronization.
The statistical analysis revealed a significant time effect
for the two transcripts assessed: mRNA levels for Per1
and Rev-erbα at 16 h were higher than those at 0–8 and
24–30 h.
Although clock gene expression in proliferating T98G
cells after DEX synchronization also showed temporal
fluctuations in the three clock genes investigated
(Supplementary Fig. 1b), the circadian rhythmicity was
lost for Rev-erbα mRNAs and for Per1 the period was
shortened to 16 h according to the periodic analysis
(Table 1). Nevertheless, the temporal variations observed
display different amplitudes and profiles of expression
with respect to patterns described in arrested cells
(Supplementary Fig. 1b). The amplitude for Per1 tran-
scripts varied 7-fold over time in arrested cells and only
1.5-fold under proliferation. Rev-erbα reached 5- and 4-
fold increases in arrested and proliferative cells, respec-
tively. In addition, synchronized proliferating cells
displayed a significant daily rhythm in levels of PER1-
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like protein by immunocytochemistry (ICC) (p < 0.005 by
analysis of variance (ANOVA)) (Fig. 1a–c), with highest
levels at 18 and 24 h after synchronization, differing from
those at 6 and 12 h. In proliferating T98G cells after trans-
fection with PX459-Bmal1 plasmid (T98G E1), levels of
Per1 mRNA and protein were substantially reduced and no
time related differences were seen in PER1-like protein
along the 24 h examined (Fig. 1b, c).
Temporal Regulation of GPL Labeling in T98G Cells
In order to investigate the circadian regulation of cellular
metabolism in T98G cells, we examined GPL labeling
with 3H-glycerol or 32P-orthophosphate for 90 min in tu-
mor cells previously synchronized with DEX and main-
tained in an arrested state or under proliferation for 48 h,
at different times after synchronization.
Table 1 Periodic analysis by COSINOR/RAIN correlation of gene expression and metabolic parameters under both growth conditions (arrest and
proliferation)
Growth condition
Partial arrest Proliferative
p value Acrophase (h) Period (h) p value Acrophase (h) Period (h)
1- Molecular level
a. mRNA expression
Per1 0.0012b 20 28 0.0256a,c 4 16
Rev-erb α 0.0461a 16 24 nsb
ChoK α 0.0045b 16–20, 48 32 nsb
Pcyt-2 0.0329a, c 12, 28 16 nsb
2- Metabolic level
a. Total GPLs 0.0159a 0 20 0.036a 20 24
b. Individual GPLs cpm pix
PC nsa 0.03a 24 32
PE 0.006b 8 32 0.036a, c 12 32
PC/PE 0.008a 4, 32 28 0.025a, c 28 32
c. Enzymatic activities
Total PAP 0.0308a 24 30 0.0277a, c 0 24
LPAAT nsa nsa
LPCAT nsb nsa
LPEAT nsa nsa
d. Redox state
WT 0.001a 0 12 0.0071a, c 0 12
E1 Non-determined 0.0185a 6 18
e. PRX expression SO3 0.038
b 6 24 0.005b 30 30
f. Endogenous GPLs content
PC Non-determined nsa
PE 0.0264b 6 24
PC/PE 0.0323a, c 12 24
g. BOR Non-determined 0.0109a, c 0–6 30
Statistical analysis was performedwith results from 3/5 independent samples for each time in T98G cell grown under arrest or proliferative conditions. To
test the time effect in the relative RNA expression or metabolic aspects, a periodic adjustment model—COSINOR—was applied for each data set
examined as described in “Materials andMethods.”When the model assumptions were infringed, the RAIN analysis was used. The COSINOR analysis
includes r2 , acrophase, and period. Acrophase denotes the time at which the variable reaches the maximum observed value; the analysis considered a
period from 12 to 30 h and significance at p < 0.05 (values in bold). Significant periodic effects of time byRAIN or COSINOR periodic model better than
linear model according AIC are in bold. Significant periodic effects of time by COSINOR, but where the whole model does not perform better than null
linear model (according AIC) are set in italics
ns, non-significant
a COSINOR
bRAIN
c Log-transformed variable
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T98G cells totally failed to uptake 3H-glycerol, irrespective
of the proliferative condition examined or time of labeling as
compared with positive controls (NIH3T3 fibroblasts) [3].
However, when 32P-phosphate was used as a general precur-
sor for GPL synthesis, we found a significant temporal varia-
tion in the labeling of total GPLs of arrested cells collected at
different times, with highest levels at 0, 16–20, and 32–44 h
after DEX synchronization and lowest levels of labeling at 8,
24, and 28 h with a period of 20 h (p < 0.016) (Fig. 2a (a);
Table 1). When cells were maintained in FBS medium after
DEX synchronization, a significant temporal variation was
also observed in GPL labeling with highest levels at 0–4 and
16–24 h and lowest levels at 8 and 28–32 h (Fig. 2a (b)).
Under this condition, the oscillation in metabolic GPL label-
ing displayed a circadian period ~ 24 h (p < 0.036) (Table 1).
When PC and PE labeling and the PC/PE ratio were
assessed separately, a significant temporal variation was
observed in arrested cells (Fig. 2b) with higher levels of
Fig. 1 Immunocytochemistry of PER1-like protein for proliferating
T98G WT and E1 cell cultures after synchronization. a, b WT (a) or
transfected cells with PX459-Bmal1 plasmid (T98GE1 cells) (b) kept in
the presence of serum were synchronized with a shock of 100 nM DEX
for 20 min and collected at different times from 0 to 24 h. Cultures were
immunolabeled with specific primary antibody for PER1-like protein
(red) and with DAPI (blue) for nuclear localization and visualized by
confocal microscopy as described in “Materials and Methods.” Scale
bar = 10 μm. c Histograms indicating relative levels of PER1-like
protein in T98G WT cells (black) or T98G E1 cells (gray) at different
times after synchronization. Data are mean ± SE. Results revealed a
significant temporal variation in levels of PER1-like protein by
immunocytochemistry (p < 0.005 by ANOVA) in WT cells, with
highest levels at 18 and 24 h after synchronization, differing from those
at 6 and 12 h. By contrast, T98GE1 cells under the same conditions
exhibited lower immunoreactivity associated with PER1-like protein
over time and no significant temporal effect at times examined. d RT-
PCR for Bmal1 (a) and Per1 (b) (a downstream target gene for Bmal1)
and the housekeeping gene tbp in T98GWT and T98GE1 cells. Results
showed a significant decrease in both transcripts in T98G E1 glial cells.
See text for further details
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Fig. 2 a Temporal variations in total 32P-GPL labeling in cultures of
T98G cells. Cells were kept in serum-free DMEM (arrest, a, left panels)
or in the presence of serum (proliferation, b, right panels) and
synchronized with a shock of 100 nM DEX for 20 min and collected at
different times. Cells were given a 90-min labeling pulse with 32P-
orthophosphate at different times after synchronization at time 0 and
processed as described in “Materials and Methods.” A significant time
effect was found in both proliferative conditions. The COSINOR
revealed a significant time effect for total 32P-GPLs (p ≤ 0.05).The
results are mean ± SEM (triplicate samples from three independent
experiments, n = 3–5/time). See text and Table 1 for further details on
statistical analysis and period determination. b Temporal variations in
32P-PC/32P-PE ratio in T98G cell culture. Cells were kept in serum-free
DMEM (arrest, a, left panels) or in the presence of serum (proliferation, b,
right panels) and synchronized with a shock of 100 nM DEX for 20 min
and collected at different times. Cells were given a 90-min labeling pulse
with 32P-orthophosphate at different times after synchronization at time 0.
GPLs were extracted and separated by TLC as described in “Materials
and Methods.” A significant time effect was found in both proliferative
conditions. The COSINOR/RAIN analysis revealed a significant time
effect for PE and the PC/PE ratio under arrest and for PC, PE, and the
PC/PE ratio under proliferation (p ≤ 0.05). The results are mean ± SEM
(triplicate samples from three independent experiments, n = 3–5/time).
See “Materials and Methods” for further details and Table 1 for the
statistical analysis and period determination. c, d Temporal variations in
GPL enzyme genes CkoKα (a, b) and Pcyt-2 (c, d) mRNA expression in
T98G cell cultures. Cells were kept in serum-free DMEM (arrest, a, left
panels) or in the presence of serum (proliferation, b, right panels) and
synchronized with DEX (100 nM) for 20 min and collected at different
times.CkoKα (a, b) and Pcyt-2 (c, d) mRNA levels were assessed by RT-
qPCR with RNA extracted from cells collected at different times during
48 h after DEX treatment at time 0; values were normalized according to
the expression of the housekeeping gene TBP. A significant adjustment to
a periodic function was obtained, illustrated by means of dashed lines (p
< 0.05). The results are mean ± SEM (triplicate samples from three
independent experiments, n = 3–5/time). See text and Table 1 for further
details on statistical analysis and period determination
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32P incorporation into PE at 16–24 and 40–48 h and into
PC at 8 h after DEX treatment (data not shown). PE label-
ing and the PC/PE ratio displayed a periodicity around 28–
32 h (p < 0.006 and p < 0.008, respectively, Table 1). A
significant variation in PC and PE labeling and in the PC/
PE ratio was also observed in proliferating cells (Table 1;
Fig. 2b) which as shown in Table 1 displayed a marked
rhythmicity, with higher levels at 24 h and a period of
32 h for all of them (p < 0.05), revealing a clear temporal
variation in membrane fluidity.
We further assessed the time variation in endogenous PC
and PE content in proliferating cells, as shown in
Supplementary Fig. 2. Although levels of PC did not vary
significantly over time, PE content and the PC/PE ratio
displayed a marked oscillation with a period of 24 h (p <
0.03) (Table 1). Pairwise comparisons revealed that PE levels
at 0 and 12 h differ from those at the peak (30 h) while for PC,
levels at 12 h were significantly lower than those at the peak
(6 h). Notably, the metabolic labeling of GPLs exhibited the
highest levels at 16–20 h, at which times the endogenous lipid
content was minimal.
Temporal Regulation of Gene Expression for GPL
Synthesizing Enzymes in T98G Cells under Different
Proliferation Conditions
In order to further investigate temporal control of GPL syn-
thesis in synchronized T98G cells maintained in an arrested
state or under proliferation, we examined the expression of
mRNAs encoding for two regulatory glycerophospholipid-
synthesizing enzymes: ChoKα and Pcyt-2 involved in PC
and PE biosynthesis by Kennedy pathways, respectively
(Fig. 2c, d). In arrested cells, ChoKα displayed a significant
rhythmicity with the highest levels at 16–20 and 48 h after
synchronization and a period of 32 h (p < 0.004, Table 1)
while cells under proliferation showed delayed peaks of ex-
pression with highest levels at 40 h after DEX shock and no
rhythmicity (Fig. 2c; Table 1).
Pcyt-2 mRNA also exhibited a rhythm in arrested cells,
peaking at 24–28 h with a period of 16 h (p < 0.04) while
proliferative cells showed delayed peaks between 28 and
40 h after DEX synchronization without periodicity (Fig. 2d;
Table 1). The amplitude of expression for ChoKα varied sig-
nificantly (7-fold) over time under both proliferative condi-
tions while for Pcyt-2, it varied from 20-fold (arrest) to 4-
fold (proliferation) over time.
Daily Variation in the Activity of Different T98G GPL
Synthesizing Enzymes
We explored the possibility that the circadian changes
observed in the metabolic labeling of total GPLs in syn-
chronized T98G cells under different proliferative states
were linked to similar variations in the activity of en-
zymes involved in the de novo synthesis of GPLs. For
this, we determined the in vitro activities of PAP (total
PAP, PAP1, and PAP2) and lysophospholipid acid acyl-
transferase (LPAAT) in homogenates of synchronized
T98G cells collected every 6 h at different times ranging
from 0 to 36 h under both proliferation conditions (with/
without serum) (Supplementary Fig. 3; Fig. 3).
LPAAT Activity
PA, the main precursor of GPLs, is synthesized by the acylation
of lysophosphatidicacid (LPA)catalyzedbyLPAAT.Insynchro-
nized cells, the acylation of LPA exhibited no significant tempo-
ral variations under either condition (Supplementary Fig. 3);
however, for proliferating cells, LPAAT activity peaked at 30 h
and the lowest levelswereseenat18hafter synchronization.Post
hoc comparisons showed that levels at 30 h differed from those
from 0 to 18 h, as well as from those at 36 h.
PAP Activity
PA, precursor of all GPLs, is dephosphorylated to DAG by
PAPs to synthesize PC and PE [17]. Since the activities of
two PAP isozymes, PAP1 and PAP2, have been found in
T98G homogenates, we assessed total and individual PAP ac-
tivities. PAP1 is primarily involved in lipid synthesis in the
endoplasmic reticulum and PAP2 is mainly involved in mem-
brane lipid signaling.
In both conditions, total PAP activity displayed a temporal
oscillation with a period between 24 (proliferation) and 30 h
(arrest) (Fig. 3; Table 1) (p < 0.03). The highest levels of activity
were found in arrested cells at 18, 24, and 30 h and the lowest at
12 h; post hoc comparisons showed that levels at 30 h differed
from those at 12 h (Fig. 3a). In the case of proliferating T98G
cells, activity levels peakedmainly at 24 h after synchronization
and post hoc comparisons showed that these levels differed
from those at 12 h (Fig. 3b). This oscillation exhibited a period
of 24 h (p < 0.03) (Table 1). In arrested cells, both PAP1 and
PAP2 activities were detected in T98G preparations but no
significant variations were found over time.
Temporal Contribution of the Different LPLAT
Activities to GPL Remodeling in Arrested
and Proliferating T98G Cells
To investigate whether the remodeling of GPLs varies across
time, we assessed the activity of LPLATs involved in the
reacylation of other lysophospholipids (Lands Cycle) in
arrested and proliferating T98G cells after DEX synchroniza-
tion. We found slight temporal variations in the activity of
LPLATs for the different GPLs examined in both conditions
tested (Supplementary Fig. 3). In arrested cells ,
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lysophosphatidylcholine acyltransferase (LPCAT) displayed a
profile of activity with the highest levels at 18, 30, and 36 h (p
< 0.015 by ANOVA); post hoc comparisons showed that
levels at 36 h differed from those at 0, 12 and 24 h and levels
at 30 h differed from those at 12 h post synchronization.
Lysophosphatidylethanolamine acyltransferase (LPEAT) ac-
tivity also exhibited a significant variation in arrested cells
(p < 0.05 by ANOVA), with levels peaking at 30 h and differ-
ing from those at times ranging from 0 to 18 h. By contrast, no
significant differences were found in activity levels for these
LPLATs in proliferating cells.
Temporal Regulation of Redox Metabolism in T98G
Cells
Redox State
In order to further investigate the metabolic/redox clock in
these cells, the redox state was assessed in cultured T98G cells
under arrest or proliferation (Fig. 4a, b). Cells were harvested
at 6 h intervals after DEX synchronization during 36 h and the
redox state of the cells was analyzed by incubation with 2′,7′-
dichlorodihydrofluorescein diacetate (0.2 μM) for 40 min as
stated in “Materials and Methods.” When the fluorescence
intensity was analyzed by flow cytometry, a significant tem-
poral variation in the cellular redox state was observed in both
growth conditions (p < 0.01 by Kruskal-Wallis) exhibiting a
period of 12 h in each situation (p < 0.008, Table 1). In another
series of studies designed to investigate the effect of the mo-
lecular clock on the redox cycles described above, the redox
state was assessed in proliferating T98G cells after
transfection with PX459-Bmal1 plasmid (T98G E1) in order
to knockdown Bmal1 expression (Fig. 4c). Under this condi-
tion, the amplitude of the 12-h cycle in the redox state was
substantially diminished and the 12-h rhythm extended to 18 h
(Fig. 4c; Table 1).
Cycles of PRX Oxidation
In a series of experiments addressed at studying the reduction/
oxidation cycles in synchronized T98G cells kept under dif-
ferent proliferative conditions, the oxidized/hyperoxidized
PRX (SO2/3-PRX) levels were determined by Western blot.
The results indicate that oxidized/hyperoxidized PRX dis-
plays a significant temporal variation in both growth condi-
tions (p < 0.05 by Kruskal-Wallis) (Fig. 5) with a period of
about 24 h (arrested cells, p < 0.04) or 30 h (proliferative cells,
p < 0.005) (Table 1). In arrested cells, SO2/3-PRX levels were
higher at 24–30 and 48 h whereas under proliferation,
oxidized/hyperoxidized PRX levels exhibited higher levels
at 12 and at 24–30 and 48 h.
Differential Time Response of Cell Viability to Bortezomib
Treatment
When T98G cells grown under proliferation were treated with
Bortezomib (500 nM) after DEX synchronization and their
viability compared with vehicle-treated controls, we found a
significant temporal effect of the drug treatment, with the low-
est levels of viability in a time window ranging between 12
and 24 h (Fig. 6). The statistical analysis clearly shows a
significant effect of time, treatment, and interaction (p <
Fig. 3 Temporal variations in total PAP activity in cultures of T98G cells.
Cells were kept in serum-free DMEM (arrest, a, left panel) or in the
presence of serum (proliferation, b, right panel) and synchronized with
a shock of 100 nM DEX for 20 min and collected at different times. The
activity of total phosphatidate phosphohydrolase (PAP) was determined
in cultures collected at different times after DEX synchronization as
described in “Materials and Methods.” The COSINOR analysis reveals
a significant time effect on enzyme activity (p < 0.03) in both proliferative
conditions. Results are the mean ± SEM of two independent experiments
(n = 4/group). See text for further details and Table 1 for the statistical
analysis and period determination
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0.0001 by ANOVA) with maximal viability levels at 6 and
30 h after synchronization, differing from all other times ex-
amined. The COSINOR analysis revealed that the observed
oscillation presented a period of 30 h (p < 0.01) (Table 1).
Furthermore, to ascertain whether the molecular clock had
any effect on the differential responses to bortezomib treat-
ment, cell viability was assessed in proliferating T98G cells
after transfection with PX459-Bmal1 plasmid (T98G E1) (Fig.
6). Under this condition, the temporal responses in terms of
T98G E1 cell viability to bortezomib treatment were substan-
tially affected as compared with control cells expressing
BMAL1. Although the temporal variation and its amplitude
were not altered in transfected cells (p < 0.0013 by Kruskal-
Wallis analysis), the oscillation exhibited a marked 6-h-phase
advance with lowest levels of cell viability at 6 and 12 h post-
synchronization
Discussion
The circadian clock operating in immortalized cells can be
synchronized by multiple signaling pathways including medi-
um exchange, trophic factors, serum, forskolin, heat shock,
and glucocorticoids, all of which elicit gene expression rhyth-
micity [1, 34]. Confluent NIH3T3 fibroblasts synchronized by
a 2-h serum shock were shown to display temporal oscillation
in the expression of the clock gene Per1 mRNA and protein,
in clear antiphase to the oscillation of GPLmetabolic labeling,
mainly of PC, which was subject to complex temporal control
involving concerted changes in the expression and/or activi-
ties of specific synthesizing enzymes [3, 4, 27, 32]. This and
other reports clearly demonstrate a very tight link and cross-
talk between the molecular circadian clock and lipid metabo-
lism [3, 4, 7, 32], reviewed by [11, 35].
Disruption of the biological clock can lead to diverse
pathologies; however, little is known about the temporal
regulation of cellular metabolisms in tumor cells.
Glioblastoma multiforme (GBM) is the most aggressive
brain tumor and human glioma T98G cells constitute a
very useful model to investigate the tumor-intrinsic circa-
dian clock. To this end, we first optimized a protocol to
obtain quiescent and proliferative T98G cells able to be
synchronized by an extracellular signal, DEX, which has
been shown to enhance circadian clock function in B16
melanoma cells and may inhibit tumor growth [36]. DEX
is commonly used in patients suffering GBM, to reduce
inflammation or as a chemotherapy adjuvant. With the
Fig. 4 Temporal variations in ROS levels in cultures of T98G cells. Cells
were kept in serum-free DMEM (arrest, a, top panel) or in the presence of
serum (proliferation, b, c, middle and bottom panels) and synchronized
with a shock of 100 nM DEX for 20 min and collected at different times.
Cells were harvested at 7-h intervals after DEX synchronization during
36 h, and the redox state of the cells was analyzed with the fluorescent
probe 2′,7′-dichlorodihydrofluorescein diacetate to a final concentration
of 0.2 μM as described in “Materials and Methods.” Cells were washed
twice with PBS 1×, and the fluorescence intensity was analyzed by flow
cytometry. A significant temporal variation was observed in T98G WT
cells (arrest, a, top panel; proliferation, b, middle panel) under both
growth conditions (p < 0.05 by Kruskal-Wallis) with a period of 12 h
(p < 0.05). c Cells kept in the presence of serum were transfected with
PX459-Bmal1plasmid (T98G E1 cells), synchronized with a shock of
100 nM DEX for 20 min, collected at different times, and the redox
state of the cells assessed as described above. Under this condition, the
amplitude of the 12-h cycle in the redox state was substantially
diminished and the 12-h rhythm extended to 18 h. The results are mean
± SEM of three independent experiments (n = 3/5 times). See text for
further details and Table 1 for the statistical analysis and period
determination
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protocols applied in culture, we were able to investigate
the function of both the circadian molecular clock and the
metabolic/redox clock [14, 35, 37, 38] in arrested and
proliferating cells in an attempt to mimic two different
growing/invasive conditions present in tumor cells.
Proliferating cells at time 0 with no DEX treatment exhib-
ited the highest percentage of cells under division at phase
S + G2/M (>65%) and the lowest percentage arrested at
Go/G1 (< 30%) as compared with DEX-treated cells over
time (Supplementary Fig. 1). These observations clearly
indicate that glucocorticoids can inhibit cancer cell prolif-
eration by limiting the number of cells in phase S and
additionally increasing the time spent in the G1 phase
(Supplementary Fig. 1) [36].
It is noteworthy that for arrested T98G cells, the circadian
molecular clock controlling the rhythmic expression of clock
genes Per1 and Rev-erbα was found to work with a period
around 24–28 h (Supplementary Fig. 1; Table 1), while for
the clock-controlled genes ChoKα and Pcyt-2 involved in
GPL synthesis, the periods were 32 and 16 h, respectively
(Fig. 2; Table 1). For most genes evaluated, the peak of
expression occurred at 16–24 h after synchronization. Also,
under these conditions, the metabolic labeling of total GPLs
and for the most abundant GPLs, PC and PE, as well as the
ratio of PC to PE, exhibited daily rhythmicity from 20 to
32 h (Fig. 2; Table 1). By contrast, under proliferation, syn-
chronized T98G cells lost their rhythmicity in the gene
Fig. 5 Temporal variations in oxidized peroxiredoxins (SO2/3-PRX)
cycles in cultures of T98G cells. Cells were kept in serum-free DMEM
(arrest, a, left panel) or in the presence of serum (proliferation, b, right
panel) and synchronized with a shock of 100 nM DEX for 20 min and
collected at different times. T98G cells were cultured under arrest or
proliferation and harvested at 7-h intervals after dexamethasone (DEX)
synchronization during 36 h in a radio-immunoprecipitation assay (RIPA)
buffer containing protease inhibitor as described in “Materials and
Methods.” Fifty micrograms of protein were separated by SDS gel
electrophoresis on 12% polyacrylamide gels. SO2/3-PRX (ab 16,830)
primary antibody was used. A significant temporal variation was
observed in both growth conditions (p < 0.05 by Kruskal-Wallis) with a
period of 24 and 30 h for arrest or proliferation, respectively (p < 0.05 by
RAIN analysis). The results are mean ± SEM of three independent
experiments (n = 3/5 times). See text for further details and Table 1 for
the statistical analysis and period determination
Fig. 6 Cell susceptibility to bortezomib treatment in cultures of T98G
cells under proliferation. Cells were synchronized with dexamethasone
(DEX, 100 nM), and bortezomib was added to a final concentration of
500 nM at different times for 36 h. Cell viability was analyzed by MTT
assay as described in “Materials and Methods.” A significant temporal
variation was observed in levels of T98G WT (black) cell viability (p <
0.0007 by Kruskal-Wallis) with a period of 30 h (p < 0.011); in T98G E1
cells withBmal1 knock-down, an oscillationwas also seen but exhibited a
marked 6 h phase advance in cell viability (gray) (p < 0.0013 by Kruskal-
Wallis). The results are mean ± SEM of three independent experiments
(n = 5–6/times). See text for further details and Table 1 for the statistical
analysis and period determination
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expression of clock and clock-controlled genes or the oscil-
lation period was found to be shortened (Table 1), as also
shown in the expression of Per1 and Per2 in glioma tissue
[39]. ProliferativeT98G cells nevertheless maintained the
daily oscillation in the labeling of total GPLs, PC and other
lipids (data not shown), as well as in the PC/PE ratio with a
circadian period close to 24 h or longer (Fig. 2; Table 1)
This likely reflects important temporal changes over time in
membrane properties (integrity, fluidity, curvature) and in
the biogenesis of new membranes for mitotic cells. The
fluctuations in GPL labeling were accompanied in both con-
ditions by concerted changes in the total activity of PAP,
which provides DAG for the synthesis of more complex
GPLs (PC, PE, TAG) peaking at 24 h (Fig. 3).
Physiological functions affected by PAP activities include
not only GPLs synthesis but also lipid signal transduction,
gene expression regulation, nuclear/endoplasmic reticulum
membrane growth, lipid droplet formation, and vacuole ho-
meostasis and fusion [40–43], reviewed in [44]. In this con-
text, a sequential but slight increase in the activity of the
acyltransferases (LPAAT) was observed at 30 h to further
provide PA as PAP substrate; moreover, the activity of the
other acyltransferases (Lands Cycle) peaked at different
times after synchronization mainly in arrested cells:
LPEAT increased at 6 and 24 h and LPCAT at 12 h
(Supplementary Fig. 3). These observations suggest that un-
der arrest, a time variation in the remodeling processes of
membrane GPLs is required whereas under proliferation
such temporally regulated events are no longer necessary;
instead, the formation of new membranes is prioritized for
cell division, as observed for the metabolic labeling of total
and individual GPLs, the PC/PE ratio and PAP activity.
Another consequence of the lack of temporal regulation in
GPL remodeling could be a shift in the membrane repair
mechanism, in turn affecting physicochemical membrane
properties in proliferative cells [20]. It is to be noted that
the generation of LPA is mainly the result of the esterifi-
cation of glycerol-3-phosphate in the de novo Kennedy
pathway whereas other lysophospholipids are formed by
the action of PLA activities as part of the deacylation-
reacylation cycle [19]. Taking this into consideration, the
possibility of a differential temporal regulation of PLA in
these cells cannot be discarded. The increase in reactive
oxygen species (ROS) observed in T98G cells under pro-
liferative conditions (Fig. 4) could also be associated with
changes in the Lands cycle. In this respect, previous reports
have shown that increased oxidant levels were able to trig-
ger PLA activation and to modulate GPLs acylation path-
ways in retina and neurons [45, 46]. Some PRX isoforms
have been shown to possess PLA activities and also to be
involved in membrane repair during oxidative stress condi-
tions [47]. Based on the results presented here, we cannot
rule out the possibility that PRX expression is associated
with PLA activity and thus with the modulation of
deacylation/re-acylation cycles.
Overall, our findings indicate that the canonical circadian
molecular clock controlling rhythms in gene expression ap-
pears to shorten the oscillation period whereas the metabolic
clock continues to function with a similar period to that re-
ported under arrest, in fine tuning with cell division (see
Fig. 7). In addition, a circadian metabolic rhythm has recently
been reported in normal quiescent fibroblasts [48] in which
the amplitude of circadian gene expression was also affected
under redox stress or metabolic inhibition.
It is now known that the oxidation-reduction cycles of PRX
proteins constitute a universal marker for circadian rhythms in
Fig. 7 Periods of molecular or metabolic rhythms in T98G cell cultures.
Cells were kept in serum-free DMEM (arrest) (black bars) or in the
presence of serum (proliferation) (gray bars) after synchronization with
a shock of 100 nMDEX for 20 min and collected at different times along
36–48 h. Periods in hours are shown for rhythms in mRNA expression of
Per1, Rev-erbα, Chok, and Pcyt2 (molecular rhythms, left panel) or for
metabolic rhythms in labeling of total GPLs (total GPLs), of PC, of PE,
PC/PE ratio, PAP activity, and PRX-SO3 (metabolic rhythms, right
panel). For the periodic analysis, a COSINOR analysis was performed,
and when the model assumptions were infringed, the RAIN analysis was
applied as described in the text. The analysis considered a period (τ)
ranging from 12 to 32 h and significance at p < 0.05. See Table 1 and
text for further details
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cells from humans, flies, fungus, bacteria, and archaea, likely
reflecting a tight temporal control in response to environmen-
tal oxidative changes by promoting an endogenous oscillation
in the generation of ROS. This mechanism, highly conserved
through evolution, may confer the ability to survive cycles of
oxidative stress [14, 15]. PRXs, having peroxidase activity,
are mainly involved in the removal of ROS. In tumor T98G
cells, significant cycles in the redox state (ROS levels) and in
the abundance of oxidized/hyperoxidized PRX were clearly
observed under both proliferative conditions examined, main-
ly displaying a bimodal rhythmicity with a 12-h period for
ROS levels (Fig. 4); this observation agrees with a recent
report supporting the idea that a cell-autonomous mammalian
12-h-clock distinct from the circadian clock coordinates met-
abolic and stress rhythms [49]. In the case of oxidized/
hyperoxidized PRX cycles, the period extends from 24 h un-
der arrest to 30 h under proliferation (Fig. 5; Table 1). Thus, at
times of low ROS content (6 and 18 h after synchronization),
levels of oxidized/hyperoxidized PRX were also lower and
when ROS levels were high at 24 h, PRX levels were also
high. Under proliferation, the overall levels of ROS are higher
than in cells under arrest; nevertheless, the cell may have other
antioxidant enzymes and molecules cooperating to detoxify
ROS at times when ROS levels are elevated [14, 15].
Moreover, PRX cycles can persist even in the absence of the
transcriptional cycles required to coordinate the circadian mo-
lecular clock [14, 15]. In this respect, our observations for the
proliferating condition clearly demonstrate that even when the
rhythmicity for expression of clock and clock-controlled
genes was lost, the metabolic oscillator driving GPL metabo-
lism, the redox state, and PRX cycles still operated with pe-
riods ranging from 12 to 24 h or longer. This remaining oscil-
latory capacity may allow tumor cells to be selectively treated
with higher sensitivity at precise times using the chemothera-
peutic agent bortezomib, as shown in Fig. 6. With this proce-
dure, the highest levels of cell death (70%) are achieved from
12 up to 24 h after DEX synchronization compared with only
~ 50% cell death at other times. In this connection, daily
rhythms of bioluminescence in Bmal1-luciferase expression
were recently shown to occur in human and mouse GBM cells
kept in culture and a circadian time-dependent sensitivity to
treatment with the DNA alkylator temozolamide, a commonly
used chemotherapeutic in GBM, was reported [50]. The drug
effect on cell growth inhibition was found to be higher near
the Bmal1/Luc peak of expression while increased sensitivity
to x-irradiation was observed in glioma tumors when Per1 and
Per2 expression was high [39].
Based on our observations, the intrinsic tumor cell clock
can be said to consist of the canonical transcriptional clock
and metabolic oscillator ticking rhythms (from 12 to 32 h)
working in unison mainly under ex vivo arrest conditions or
in a presumably more independent and dissociated manner in
proliferating cells. In this connection, intense cross-talk has
been reported between the two oscillators as seen for the
PRXSO2/3 cycles in circadian clock mutants displaying an al-
tered circadian phase relative to wild type [14]. Here, we fur-
ther investigated the interaction between the two oscillators in
tumor cells, evaluating the effect of the canonical transcrip-
tional clock alteration by knocked-down Bmal1 on cellular
processes in proliferating cells. In fact, cells transfected with
the PX459-Bmal1 plasmid exhibited a higher percentage of
arrested cells (77% in G0/G1 phases) than in controls, de-
creased mRNA and protein levels for the target clock gene
Per1 and loss of PER1-like protein time variation (Fig. 1;
Supplementary Fig. 1). Moreover, under this condition, the
amplitude of the 12-h cycle in the redox state was substantially
diminished and the rhythm extended to 18 h period (Fig. 4)
while the circadian responses in cell viability to bortezomib
treatment exhibited a marked 6-h-phase advance (Fig. 6).
In summary, our observations allow us to establish some
degree of correlation among cell state, redox balance and GPL
metabolism: under proliferation, synchronized cells experi-
enced the highest susceptibility to the chemotherapeutic agent
Bortezomib at a temporal window beginning around 12 h at
which the redox state was high but GPL metabolism (endog-
enous levels, 32P-labeling together with total PAP and some
LPLATs activities) was low. The proteasome inhibitor
bortezomib was shown to promote ROS generation in mito-
chondria of different cancer cells and ultimately to cause ap-
optosis [51]; these observations further support our results
showing that the highest cell susceptibility to bortezomib
treatment was found when the peak in ROS was attained.
Conclusions
Our findings reveal that tumor T98G cells contain an intrinsic
cellular clock that regulates several cellular and metabolic
functions. GBM cells were able to be synchronized by DEX
and to retain the oscillatory condition under proliferation.
Moreover, even when cells lost their rhythmicity in the ex-
pression of clock and clock-controlled genes or when the pe-
riod of oscillation was shortened under proliferation, they still
continued to oscillate for a number of metabolic/redox activ-
ities such as GPL biosynthesis, GPL enzyme activities, redox
state, and PRX cycles with a similar periodicity to that under
arrest (see Fig. 7). This rhythmic capacity provides an oppor-
tunity to improve chemotherapeutic treatment at precise times
after cell synchronization and thereby significantly increase
cell death above the average of 50%. Owing to the fact that
a disruption of the molecular clock can disturb redox rhythms
and differential temporal cell susceptibility to chemotherapy
treatment, we may infer that cross-talk between the oscillators
takes place in tumor cells to ensure tumor growth and survival
over time. Furthermore, regardless of the precise nature of the
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link between them, molecular and metabolic oscillators work
in unison to maintain cellular homeostasis.
Materials and Methods
Materials
All reagents were of analytical grade. [32P]-Na2 orthophos-
phate (specific activity 285.5 Ci/mg),[2-3H]-glycerol and
[3H]-oleic acid (9.20 Ci/mmol) were purchased from NEN
Life Science Products (Boston, MA, USA). Alugram SIL G/
UV254 TLC silica gel 60-precoated sheets were from
Macherey-Nagel (Duren, Germany). GPL standards, MgCl2,
and ATP were from Sigma (St. Louis, MO, USA).
T98G Cell Cultures
T98G cells (ATCC, cat. No. CRl-1690, RRUD: CVCL-0556,
Manassas, VA, USA) tested positive for glial cell markers and
negative for mycoplasma contamination. Cells were grown in
DMEM (Gibco, BRL, Invitrogen, Carlsbad, CA, USA) sup-
plemented with 10% FBS according to [52]. After the desired
degree of confluence had been achieved in a CO2 incubator at
37 °C for 24–48 h, cells were synchronized by a 20-min shock
with 100 nMDEX and allowed to grow for another 48 h in the
presence (proliferative condition) or absence (quiescent con-
dition) of 5% FBS-DMEM. After DEX synchronization (time
0), cells were collected at 4–8-h intervals during 48 h.
Glycerophospholipid Labeling
The incorporation of [32P]-orthophosphate or [3H]-glycerol
into GPLs of T98G cells in culture was assessed at different
times from 0.5 to 48 h every 4 h. A 90-min labeling pulse of
[32P]-Na2Orthophosphate (10 μCi/well) or [
3H]-glycerol
(8.5 μCi/well) was given to cultures of each condition at dif-
ferent times after DEX synchronization. Cells were harvested
90 min after addition of the radioactive precursor to the cul-
tures at the different phases assessed and processed for GPL
labeling.
Determination of Radioactivity
in Glycerophospholipids
The labeling of total GPLs was determined according to
Guido and Caputto [29]. In brief, cell preparations washed
twice with 1-mM-cold phosphate-buffered saline (PBS) were
resuspended in 1 mL of water and precipitated with the same
volume of 10% trichloroacetic acid (TCA) and 1% phospho-
tungstic acid (PTA). After centrifugation (1000 rpm, 15 min),
the supernatant fraction was separated. Pellets were washed
three times with 5% TCA and 0.5% PTA and once with water
by successive resuspension and centrifugation. Total GPLs
were extracted with chloroform:methanol (2:1, v/v) as de-
scribed in [53]. Lipids were resuspended in 40 μL of
chloroform:methanol (1:1, v/v) for further separation by thin-
layer chromatography (TLC). Radioactivity incorporated into
individual GPLs was assessed by autoradiography. The pro-
tein content in cell preparations was determined by the Bio-
Rad protein assay, based on the method of Bradford [54],
using bovine serum albumin as standard.
Chromatographic Separation of Individual
Glycerophospholipids
Individual GPLs were separated by TLC using silica gel 60
plates previously impregnated in 1.2%H3BO3 (in ethanol:water
1:1, v/v) (fromMacherey-Nagel; Duren, Germany). The solvent
system chloroform:methanol:water:ammonium hydroxide
(120:75:6:2, v/v) constituted the mobile phase [55]. The bands
corresponding to labeled GPLs were scraped off the silica
plate and [32P]-radioactivity was quantified using a liquid
scintillation counter or autoradiography. In the latter case,
the signal intensities from the individual GPL bands were
calculated as the ratio between the signals of one individ-
ual GPL of each sample in percent of pixels and the total
pixels for each sample using the gel Analyzer software.
The PC/PE ratio was calculated as the ratio between the
PC and PE content of each sample irrespective of any
form of normalization.
In Vitro Determination of LPLAT
Proliferating or arrested T98G cells from 100 mm dishes were
collected at different times from 7 to 56 h after DEX (100 mM)
shock in 1 mL of PBS, lyophilized, and resuspended in 50 μL
ultrapure H2O-containing protease inhibitors (2 μg/mL
leupeptin; 1 μg/mL pepstatin; 1 μg/mL aprotinin). Cell lysates
were used as a source of enzyme and endogenous
lysophospholipids for determination of total LPLAT activity.
The activity of LPLAT was determined as “in vitro” labeling
by measuring the incorporation of [3H]-oleate from[3H]-oleic
acid (9 .20 Ci /mmol) in to di ffe ren t endogenous
lysophospholipid acceptors as described in [4, 31, 56]. Under
these experimental conditions, changes in the activity assessed
may reflect both changes in enzyme activity and in the content
of endogenous lysophospholipids (co-substrates). For the en-
zyme reaction the standard incubation mixture contained
60 mM Tris–HCl, pH 7.8, 4 μM [3H]-oleic acid (105dpm/as-
say), 10 mM MgCl2, 10 mM ATP, 75 μM CoA, and 20 μl of
cellular homogenates containing 80 μg of protein in a final
volume of 80 μL. The reaction was started by the addition of
radiolabeled substrate resuspended in assay buffer followed by
incubation for 30 min with shaking at 37 °C and was stopped
by addition of 5 mL chloroform:methanol (2:1, v/v). Blanks
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were prepared using boiled cellular homogenates and incubated
as described above (less than 0.5% of the activity observed in
the experimental samples). The lipids were extracted according
to the method of Folch [57]. The lipid extract was dried under
N2, resuspended in chloroform/methanol (2:1, v/v) and spotted
on silica-gel H plates. Unlabeled phospholipids were used as
standards. The chromatograms were developed by two-
d im e n s i o n a l TLC u s i n g a s s y s t em s o l v e n t s
chloroform:methanol:ammonia (65:25:5, v/v/v) for the first di-
mension and chloroform:acetone:methanol:acetic acid:water
(30:40:10:10:4, v/v/v/v) visualized with iodine vapors. The
spots corresponding to the different GPLs, phosphatidic acid
(PA), PC and PE, were scraped off and radioactivity was deter-
mined by liquid scintillation.
Determination of PAP Activity
Proliferating or arrested T98G cells from 100 mm dishes were
collected at different times from 7 to 56 h after synchroniza-
tion in 1 mL of PBS and resuspended in 50 μL ultrapure H2O
containing protease inhibitors (2 μg/mL leupeptin; 1 μg/mL
pepstatin; 1 μg/mL aprotinin). Total PAP, PAP-1 and PAP-2
activities were determined by monitoring the rate of release of
1,2-diacyl-[2-3H]-glycerol (DAG) from [2-3H]-phosphatidic
acid (PA) as previously described by Pasquaré and Giusto
[58, 59]. Total PAP activity was determined in an assay con-
taining 50mMTris-maleate buffer, pH 6.5, 1 mMDTT, 1 mM
EDTA and 1 mM EGTA, 0.2 mMMg2+, and 80 μg of protein
from the T98G preparations in a volume of 0.2 mL. The reac-
tion was started by adding 0.6 mM of [2-3H]-phosphatidate
plus 0.4 mM PC. Further incubations were carried out after
pre-incubating the enzyme for 10 min with 4.2 mM NEM
which inhibits PAP1 activity; this activity was labeled as
PAP2 and the difference between total and PAP-2 activity
was labeled as PAP1 activity. The reaction was stopped at
20 min by addition of chlorophorm:methanol (2:1, v/v).
DAG was separated by gradient-thickness thin-layer chroma-
tography on silica gel G [60] and developed with
hexane:diethylether:acetic acid (35:65:1, v/v/v). In this system,
DAG migrates to three quarters of the plate and PA and MAG
stay at the origin. To separate monoacylglycerol (MAG) from
PA, the chromatogram was rechromatographed up to the mid-
dle of the plate using hexane:diethylether:acetic acid
(20:80:2.3, v/v/v) as developing solvent. Each type of PAP
activity was expressed as the sum of labeled DAG plus
MAG × (min × μg of protein)−1.
Redox State
Proliferating or arrested T98G cells grown as indicated above
were harvested at 7-h intervals after DEX (100 nM) synchro-
nization during 36 h, and the redox state of the cells was
analyzed by flow cytometry as described in [61]. Briefly, the
growth medium was removed and the cells were washed with
cold PBS 1× and harvested by trypsinization; 4 × 105 cells
were resuspended in PBS 1× and incubated with 2′,7′-
dichlorodihydrofluorescein diacetate at 0.2 μM final concen-
tration for 40 min at 37 °C. The cells were washed twice with
PBS 1×, and the fluorescence intensity was measured by flow
cytometry at 530 nm when the sample is excited at 485 nm. A
negative control including cells without the fluorescent indi-
cator was used.
Peroxiredoxin Expression
T98G cells were cultured under partial or proliferative growth
conditions as indicated; cells were harvested at 7 h intervals after
DEX (100 nM) synchronization during 36 h in radio-
immunoprecipitation assay (RIPA) buffer containing protease
inhibitor (Sigma). Total protein content in the homogenates
was determined by the Bradford method. Cell lysates were re-
suspended in sample buffer and heated at 90 °C for 5 min. Fifty
micrograms of protein were separated by SDS gel electrophore-
sis on 12% polyacrylamide gels as reported by [3]. SO2/3-PRX
(ab16830, Abcam cat. No. ab16830, RRID: AB-443491; dilu-
tion 1:500) primary antibodies were incubated overnight at 4 °C,
and secondary antibodies were incubated for 1 h at room tem-
perature. Finally, themembraneswere scanned using anOdyssey
IR Imager (LI-COR Biosciences). Densitometry quantification
of specific bands was carried out with ImageJ software.
RNA Isolation and Reverse Transcription
Total RNA was extracted from cell homogenates using
TRIzol® reagent following the manufacturer’s specifications
(Invitrogen). The yield and purity of RNAwere estimated by
optical density at 260/280 nm. Two micrograms of total RNA
was treated with DNAse (Promega) and utilized as a template
for the cDNA synthesis reaction using MMLV reverse tran-
scriptase (Promega) and an equimolar mix of random
hexamers (Biodynamics) in a final volume of 25μL according
to the manufacturer’s indications.
Real-Time PCR (qPCR)
Quantitative RT-PCR was performed using SYBR Green or
TaqMan Gene Expression Assays in a Rotor Q Gene
(QIAGEN). The primer/probe sequences are summarized in
Supplementary Table 1. The amplification mix contained
2 μL of the cDNA, 2 μL 20× mix primer/probe or 300 nM
Forward-Reverse TBP primers, and 7.5 μL of Master Mix 2×
(Applied Biosystems) in a total volume of 15 μL. The cycling
conditionswere 10min at 95.0 °C, and 45 cycles of 95.0 °C for
15 s, 60.0 °C for 30 s, and 72 °C for 30 s. The standard curve
linearity and PCR efficiency (E) were optimized. We used the
2−ΔΔCT according to Livak and Schmittgen [62] and Larionov
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et al. [63] and TBP as the reference gene [3, 64]. Each RT-PCR
quantification experiment was performed at least in duplicate
(TaqMan or SYBR) for each sample (n = 2–5/sample).
Propidium Iodide Staining and Flow Cytometry
T98G cells grown in DMEM supplemented with 10% FBS
were grown for 24–48 h and then synchronized by a 20-min
DEX shock. After synchronization, cells were maintained in
the presence or absence of 5% FBS-DMEM and collected at
different times (0, 4, 8, 16, and 24 h), washed in cold PBS
buffer, and fixed with ice cold 70% ethanol for at least 24 h.
Cell pellets were resuspended in 150 μL of staining solution
(PBS containing 50 μg/mL propidium iodide and 10 μg
RNAse A) as reported [3]. Cell cycle analysis was performed
with 60,000 cells on a flow cytometer (DB Bioscience). The
analysis program used was ModFit software (Verity Software
House, Topsham, Maine, USA).
Knock-Down of Bmal1 Expression in T98G Cells
by CRISPR/cas9
Bmal1 expression was disrupted in transfected T98G cells
using the CRISPR/Cas9 genomic editing tool as previously
described [65]. Briefly, we designed single guide RNAs specif-
ically targeting exon 2 of the human Bmal1 gene and subcloned
it into the PX459 vector (Addgene) to obtain the PX459-Bmal1
plasmid. The primer sequence corresponding to the single
guide RNAwas 5′CTGGCTAGAGTGTATACGTT 3′ and the
complementary sequence 5′ GACCGATCTCACATATGCAA
3′. T98G wild-type cells were transfected with Lipofectamine
2000 (Invitrogen) and selected with puromycin (2 μg/mL) for
10 days. The pool of selected T98G cells was labeled as T98G
E1. The disruption of Bmal1 gene expression was checked by
RT-PCR and shown to be at least 50% lower than in the WT
control (Fig. 1d). Additional effects were found on the cell cycle
phases by flow cytometry (Supplementary Fig. 1c) and on the
expression of the downstream target gene Per1 by RT-PCR and
immunocytochemistry (Fig. 1c, d).
Immunocytochemistry
ICCwas performed as described [66]. Briefly, cultured cells were
fixed for 15 min in 4% paraformaldehyde in PBS and 10 min in
methanol. Coverslips were washed in PBS, treated with blocking
buffer (PBS supplemented with 0.1%BSA, 0.1%Tween 20, and
0.1% glycine) and incubated overnight with the PER1 antibody
(Abcam cat. No. ab3443 RRID:AB_303805, dilution 1:100).
They were then rinsed in PBS and incubated with goat anti-
rabbit IgG (Jackson 549 antibody 1:1000) for 1 h at room tem-
perature (RT). Coverslips were finally washed thoroughly and
visualized by confocal microscopy (FV1200; Olympus, Tokyo,
Japan). Cellular nuclei were visualized by DAPI staining.
Bortezomib Treatment of Proliferating T98G Cells
After Synchronization and Determination of Viability
Cells were plated in 96-well plates at a density of 1 × 104 and
were allowed to attach overnight at 37 °C. Cultured cell were
synchronized with DEX and then either left untreated (posi-
tive control) or treated with bortezomib at different times (h) at
500 nM final concentration for 36 h. After incubation, 10 μL
of MTT reagent (5 mg/mL; Sigma) were added to each well,
and plates were further incubated for 2 h at 37 °C as described
[67]. Then, 100 μL of DMSO:isopropanol (1:1, v/v) was
added to each well followed by incubation for a few minutes
at room temperature protected from light. Samples were ana-
lyzed at a wavelength of 570 nmwith a reference at 650 nm in
an Epoch Microplate Spectrophotometer.
Statistics
Statistical analyses involved a one- or two-way ANOVA to
test the time or drug treatment effects and Kruskal-Wallis (K-
W) when the normality of residuals was infringed. Pairwise
comparisons were performed by the Duncan test when appro-
priate. For further periodic analysis, we performed a
COSINOR analysis [68], and when the model assumptions
were infringed, we used the RAIN analysis [69]. The analysis
considered a period (τ) ranging from 8 to 32 h, and significant
at p < 0.05.
To determine the periodic behavior of the different vari-
ables, all of them were analyzed using linear-mixed models
applying the “lme” function of the “nlme” package (Pinheiro
J, Bates D, DebRoy S, Sarkar D & R Core Team 2017. nlme:
Linear and Nonlinear Mixed Effects Models, R package ver-
sion 3.1-131.). The experiments and their repeats were incor-
porated as nested random effect factors. Time was considered
as a fixed effect factor, including a linear component (ZT) and
a periodic component (2 × π × (ZT − ω) × τ − 1). The linear
component accounts for monotonous, non-periodic effects of
time, while the periodic component accounts for the oscilla-
tions present in the variable. Parameters such as phase (ω) and
period (τ) were adjusted through an optimization process com-
paring models using the Akaike Information Criterion (AIC).
In this optimization process, the intervals included in the sam-
pling design from 12 and up to 32 h were tested as possible
periods. The phases tested correspond to the sampling design
times from zero to the maximum period contemplated.
Additionally, the best fitted model was compared, using the
procedure described, with a null model with the same random
effect factors but with only the linear component of time (ZT)
as a fixed effect factor. In all cases, the assumptions of nor-
mality and homogeneity of variance of the residues were test-
ed. The logarithmic transformation of the variables was only
applied when the assumptions were not fulfilled. The propor-
tion of the variance explained by the fixed effect factors, such
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as the effect of both linear and periodic time on each variable,
was estimated according to Nakagawa et al. [68, 70]. When
the violation of the assumptions could not be corrected for a
certain variable, they were analyzed using the RAIN algo-
rithm [69], for which the values of the repeats were averaged,
the measurements were standardized by experiment and the
linear effect of time was discounted when necessary, before
applying the RAIN algorithm. All analyzes were carried out in
the R environment (R Core Team 2017. R: A language and
environment for statistical computing, Vienna, Austria URL:
https://www.r-project.org).
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